Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA) — Kazuo Miyazawa (2018) | RDL Network
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA)
Article 2018 en
Authors
KM
Kazuo Miyazawa
DP
Daniele Pastori
CH
Christoph Hammerstingl
Abstract
1 min read
Biomarkers of inflammation are significantly associated with LA/LAA thrombus outcomes in AF patients prospectively treated with rivaroxaban.
Ahmed Qureshi, Paolo Melidoro, Maximilian Balmus, Shaheim Ogbomo-Harmitt, Steven E. Williams, Professor Gregory Lip, David Nordsletten, Oleg Aslanidi, Adelaide de Vecchi
Ahmed Qureshi, Maximilian Balmus, D. Yu. Nechipurenko, Фазоил И. Атауллаханов, Steven E. Williams, Professor Gregory Lip, David Nordsletten, Oleg Aslanidi, Adelaide de Vecchi
Discussion(0)
No comments yet. Be the first to comment.